Table 3: ADMSCs effect on acute renal injury, regenerative and chronicity scores in the outer stripe of the outer medulla of rat kidney after cisplatin (n = 5 in each group for each time subgroup; mean ± SD).

	Control	Cispl.	Cispl.+ C.Medium	Cispl.+ ADMSC
Necrotic tub.
4	0.0±0.0	12.6±2.1*	8.4±1.7*	3.9±0.3*°
7	0.0±0.0	8.6±1.3*‡	8.3±1.5*	4.6±0.4*°
11	0.0±0.0	7.4±1.8*‡	7.5±2.2*	2.6±0.2*°‡†
30	0.0±0.0	4.7±0.1*‡†•	2.4±0.3*‡†•	1.0±0.6*°‡†•
Inflam. cells
4	0.0±0.0	8.8±1.3*	8.4±1.6*	1.8±0.2*°
7	0.0±0.0)	8.4±1.6*	8.3±1.9*	1.5±0.3*°
11	0.0±0.0	8.5±1.1*	8.1±1.5*	0.0±0.0°‡†
30	0.0±0.0	4.7±0.2*‡†•	4.4±0.3*‡†•	0.0±0.0°‡†
Reg. Tub.
4	0.0±0.0	0.0±0.0	0.0±0.0	1.2±0.2*°
7	0.0±0.0	0.0±0.0	0.0±0.0	2.7±0.2*°‡
11	0.0±0.0	0.0±0.0	0.0±0.0	7.5±1.6*°‡†
30	0.0±0.0	1.4±0.2*‡†•	1.6±0.3*‡†•	7.4±2.9*°‡†
Mitosis
4	0.0±0.0	0.0±0.0	0.0±0.0	2.2±0.8*°
7	0.0±0.0	0.0±0.0	0.0±0.0	3.7±0.2*°‡
11	0.0±0.0)	1.7±0.2*‡†	1.5±0.3*‡†	4.5±0.3*°‡†
30	0.0±0.0	1.7±0.2*‡†	1.5±0.2*‡†	4.9±0.9*°‡†
Solid Sheets
4	0.0±0.0	0.0±0.0	0.0±0.0	2.8±0.8*°
7	0.0±0.0	0.0±0.0	0.0±0.0	4.8±0.6*°‡
11	0.0±0.0	0.0±0.0	0.0±0.0	5.7±0.5*°‡
30	0.0±0.0	1.3±0.2*‡†•	1.4±0.4*‡†•	6.9±2.8*°‡
Int. Fibrosis
4	0.0±0.0	0.0±0.0	0.0±0.0	0.0±0.0
7	0.0±0.0)	23.7±0.91*‡	23.1±1.4*‡	4.6±0.3*°‡
11	0.0±0.0	34.2±1.3*‡†	32.8±2.3*‡†	11.9±1.8*‡°†
30	0.0±0.0)	47.6±2.6*‡†•	43.7±2.7*‡†•	17.8±1.7*°‡†•
Atrophic Tub.
4	0.0±0.0	13.3±2.3*	12.5±1.4*	6.5±0.3*°
7	0.0±0.0	12.7±1.2*	12.5±1.3*	4.7±0.4*°‡
11	0.0±0.0	12.4±0.8*	12.3±0.6*	3.8±1.8*°‡
30	0.0±0.0	4.4±0.2*‡†•	4.6±0.2*‡†•	2.8±0.6*°‡†

Significant difference compared to corresponding * control, ^° cisplatin groups

Significant difference compared to intragroup day4^‡, day7^†, day11^• Kruskal-Wallis test at P≤0.05